Schedule 13G ownership disclosure

KARYOPHARM THERAPEUTICS INC

Security class unavailable · CUSIP: 48576U106

Event date: 2021-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.6200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-21-000679
Form type
SC 13G/A
Filer
Karyopharm Therapeutics Inc.
CIK
CIK 1503802
Filed
Oct 12, 2021
Reporting period
Sep 30, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub